Investing Profile

Tom Woiwode

VC

Photo of Tom Woiwode, Managing Partner at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Versant Ventures Managing Partner
7
$102.2M
CompanyStageDateRound SizeTotal Raised
Tempest Therapeutics
Series BMar 2018$70M
$70M
Gritstone Oncology
Series BSep 2017$93M
Series AOct 2015$102M
$195M
Co-investors: Peter Svennilson (The Column Group), Anthony Philippakis (GV)
Vividion Therapeutics
Series AFeb 2017$50M
$50M
Co-investors: Kristina Burow (ARCH Venture Partners)
Therachon
Series AJan 2017$5M
$40M
Co-investors: Sara Nayeem (Avoro Ventures)
Anokion
Series AMay 2014$37.5M
$37.5M
Co-investors: Jack Nielsen (Vivo Capital), Florent Gros (Novartis Venture Funds)
Saegis Pharmaceuticals
Series BNov 2003$30M
$30M